Bisphenol A (BPA), a xenoestrogenic endocrine-disrupting chemical, is widely used in the manufacture of polycarbonate plastics and epoxy resins, such as food and drink containers, baby bottles, and dental sealants. In addition, almost 8 billion pounds and approximately 100 tons of BPA are released into the atmosphere every year.^[@bib1]^ Consistent with its widespread presence, urinary BPA can be detected in \>90% of Americans.^[@bib2]^ The possible risks of BPA to human health have caused growing concern and worldwide debates regarding its possible association with obesity,^[@bib3]^ diabetes,^[@bib2]^ neurobehavioral disorders,^[@bib4]^ carcinogenic hypersensitivity,^[@bib5]^ and reproductive impairments.^[@bib6]^

In \>80% of sterile women, lower antral follicle counts and a smaller ovarian volume have been associated with higher levels of BPA in urine.^[@bib7]^ Moreover, perinatal exposure to BPA results in a decline in reproductive capacity^[@bib8]^ and alters early oogenesis in female mice.^[@bib9]^ In males, perinatal exposure to BPA affects fertility and has the potential to induce disruptions in Sertoli cell junctional proteins, which have a crucial role in spermatogenesis.^[@bib10]^ Furthermore, urinary BPA may be associated with decreased semen quality and increased sperm DNA damage.^[@bib11]^ However, there is also evidence indicating that exposure to BPA does not affect the fertility of female rats^[@bib12]^ and does not decrease the epididymal sperm count.^[@bib13]^ Therefore, the possible reproductive impairments resulting from BPA exposure remain controversial.

Growing evidences show that BPA has the capacity to disrupt meiotic events and subsequently impair reproductive function; BPA exposure has been reported to impair chromosome synapsis and homologous chromosome segregation,^[@bib14]^ induce synaptic defects, such as end-to-end chromosome associations and asynapsis,^[@bib9]^ and delay meiotic progression.^[@bib15]^ Furthermore, recent studies have demonstrated that BPA exposure inhibits meiotic double-strand break repair,^[@bib14]^ induces meiotic aneuploidy,^[@bib16]^ and eventually causes meiotic arrest^[@bib17]^ or chromosomal abnormalities.^[@bib18]^ Nevertheless, most of these studies were performed in females, and evidence is lacking with regard to the effect of BPA exposure on meiosis in males. Moreover, mechanisms with regard to BPA-induced meiotic abnormalities remain unclear.

Therefore, we performed an *in vivo* study to evaluate the possible effects of BPA on reproductive function and the progress of meiosis in adult male rats and to explore relevant mechanisms involved.

Results
=======

ER antagonism abolished the BPA-induced sperm count reduction
-------------------------------------------------------------

After 60 consecutive days of exposure, treatment with 200 *μ*g/kg/d of BPA and 17*β*-estradiol (E~2~) significantly reduced the epididymal sperm counts; the effect of BPA was reversed by ICI pretreatment ([Figure 1a](#fig1){ref-type="fig"}). A histological examination showed fewer sperm in the cauda epididymal ducts following BPA treatment at 200 *μ*g/kg/d compared with the control group, which was abolished by ICI pretreatment ([Figures 1e--l](#fig1){ref-type="fig"}). Nevertheless, no significant difference was found in relative body weight, testes weight, or epididymides weight ([Figures 1b--d](#fig1){ref-type="fig"}). However, E~2~ administration significantly reduced the relative epididymides weight ([Figure 1d](#fig1){ref-type="fig"}).

No changes in sperm parameters or serum sex hormone levels
----------------------------------------------------------

We evaluated sperm parameters and sex hormone levels to explore the underlying mechanism of the decreased sperm counts. No significant differences were found in sperm motility ([Figure 2a](#fig2){ref-type="fig"}) or morphology ([Figure 2b](#fig2){ref-type="fig"}). Annexin V/propidium iodide (PI) staining also demonstrated no changes in apoptotic sperm ([Figure 2c](#fig2){ref-type="fig"}). Moreover, following BPA treatment, no significant differences were observed in serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), or testosterone levels, which regulate spermatogenesis ([Figures 2d--f](#fig2){ref-type="fig"}). However, we found a greater than threefold reduction in the serum testosterone level following E~2~ treatment ([Figure 2f](#fig2){ref-type="fig"}).

ER antagonism blocked BPA-inhibited spermiation
-----------------------------------------------

The lack of alteration in sperm parameters and sex hormone levels suggested that BPA may directly exert its effect on the testes. An analysis of the seminiferous epithelium stage revealed that the alterations were focused in stages VII, VIII, and IX. Significant increases in stages VII and IX and decrease in stage VIII were observed following BPA administration; rats treated with E~2~ displayed similar results ([Figure 3a](#fig3){ref-type="fig"}). In the next experiment, we found that ICI pretreatment significantly reversed the BPA-induced increase in stage VII ([Figure 3b](#fig3){ref-type="fig"}) and BPA-induced decrease in stage VIII ([Figure 3c](#fig3){ref-type="fig"}).

ER antagonism prevented BPA-induced meiotic disruption
------------------------------------------------------

As previously described,^[@bib19]^ FACS analysis of all testicular cells showed three peaks according to cellular DNA content: 1C, 2C, and 4C cells. 1C cells were typically spermatids, 2C cells included somatic cells, spermatogonia, and secondary spermatocytes, and 4C cells represented cells in the G2/M phase and primary spermatocytes. BPA 200- ([Figure 4Ab](#fig4){ref-type="fig"}) and E~2~- ([Figure 4Ac](#fig4){ref-type="fig"}) treated rats showed an increase in 4C cells and a decrease in 1C cells after treatment compared with the control group ([Figure 4Aa](#fig4){ref-type="fig"}). BPA administration significantly reduced the percentage of 1C cells ([Figure 4Ba](#fig4){ref-type="fig"}) and increased the percentage of 4C cells ([Figure 4Bc](#fig4){ref-type="fig"}), which were prevented by ICI pretreatment ([Figures 4Ba and Bc](#fig4){ref-type="fig"}). However, no significant differences were found in 2C cells between the groups ([Figure 4Bb](#fig4){ref-type="fig"}).

To further explore how BPA disrupts meiotic progression, we utilized SYCP3, *γ*H2AX, and DAPI staining to investigate the specific spermatocyte stages in meiosis I: leptotene ([Figure 4Ca](#fig4){ref-type="fig"}), zygotene ([Figure 4Cb](#fig4){ref-type="fig"}), pachytene ([Figure 4Cc](#fig4){ref-type="fig"}), and diplotene ([Figure 4Cd](#fig4){ref-type="fig"}) spermatocytes, as previously described.^[@bib20]^ Both BPA and E~2~ administration significantly reduced the percentage of spermatocytes in the leptotene ([Figure 4Da](#fig4){ref-type="fig"}) and zygotene stages ([Figure 4Db](#fig4){ref-type="fig"}) and increased the percentage of spermatocytes in the pachytene stage ([Figure 4Dc](#fig4){ref-type="fig"}) compared with the control group, which were significantly inhibited by ICI pretreatment ([Figures 4Da and Dc](#fig4){ref-type="fig"}). However, no significant differences were found in the diplotene stage between the groups ([Figure 4Dd](#fig4){ref-type="fig"}).

ER antagonism blocked BPA-induced persistent meiotic DNA strand breaks (mDSBs) and checkpoint activation in pachytene spermatocytes
-----------------------------------------------------------------------------------------------------------------------------------

In spermatocytes, *γ*H2AX is spatially and temporally linked to mDSBs in the leptotene and zygotene stages, and in the pachytene stage, disappears from synapsed autosomes but remains on the sex chromosomes.^[@bib21]^ However, unresolved mDSBs or their accumulations in the pachytene stage may delay meiotic progression.^[@bib22]^ Thus, experiments were conducted to determine whether BPA could induce the persistence of mDSBs. As shown in [Figure 5a](#fig5){ref-type="fig"}, normal rat spermatocytes in the pachytene stage demonstrated intense immunopositive staining for *γ*H2AX localized to the sex body, which contains the unpaired regions of the X and Y chromosomes; *γ*H2AX immunostaining of the autosomes showed few or negative foci on each pachytene spermatocyte. However, pachytene spermatocytes obtained from BPA- and E~2~-treated rats showed a clear increase in *γ*H2AX foci on the autosomes. In addition, these pachytene spermatocytes exhibited chromosomal abnormalities, including asynapsis, chromosomal aberrations, and interrupted regions of SYCP3 staining. The percentage of *γ*H2AX-positive spermatocytes significantly increased following both BPA and E~2~ administration. However, this BPA-induced increase was blunted following ICI pretreatment, although there was still a significant difference compared with the control group ([Figure 5c](#fig5){ref-type="fig"}). These effects of BPA and E~2~ were confirmed by an alkaline comet assay to detect the extra mDSBs in pachytene spermatocytes. Following BPA and E~2~ treatment, a significant increase was found in tail moment compared with the control group. This BPA-induced increase was also blocked following ICI pretreatment ([Figure 5d](#fig5){ref-type="fig"}). Furthermore, results from western blot showed an increased levels of *γ*H2AX in BPA- and E2-treated rats, which was also abolished following ICI pretreatment ([Figure 5e](#fig5){ref-type="fig"}). In pachytene spermatocytes, the phosphorylated ataxia--telangiectasia mutated (p-ATM) signals clearly overlapped with the XY chromosomes, which were still unsynapsed at this stage. Following BPA and E2 exposure, the p-ATM signals became diffuse around the XY chromosomes and also on the autosomes ([Figure 5b](#fig5){ref-type="fig"}). Western blot showed that BPA and E~2~ treatments significantly increased the levels of its downstream signal phosphorylated checkpoint kinase 2 (p-Chk2), but these increases in BPA-treated rats were blocked by ICI pretreatment ([Figure 5f](#fig5){ref-type="fig"}).

ER antagonism abolished BPA-induced germ cell apoptosis
-------------------------------------------------------

Considering that ATM/Chk2-mediated checkpoint activation may result in not only cell-cycle delay but also apoptosis if the mDSBs were not properly repaired, we investigated whether germ cell apoptosis was triggered. Following BPA and E~2~ treatments, there was a significant elevation of testicular apoptotic cells, as examined by terminal dUTP nick-end labeling (TUNEL) staining ([Figure 6a](#fig6){ref-type="fig"}). Apoptotic cells occur predominantly in spermatogonia and primary spermatocytes and less in secondary spermatocytes. Semi-quantitative analysis by TUNEL-positive cells/100 seminiferous tubules showed that there was a significantly higher incidence of testicular apoptotic cell in BPA-treated rats than control rats, which could be almost completely attenuated by ICI pretreatment ([Figure 6b](#fig6){ref-type="fig"}).

The apoptosis was initiated by a caspase cascade. We therefore addressed whether BPA-induced apoptosis was through caspase signaling. Caspase-3 converged with various death signals and has a key role in inducing apoptosis; thus, the expression of active caspase-3 were determined in this study. As expected, BPA and E~2~ treatments increased the expression of active caspase-3. Following ICI pretreatment, the active caspase-3 activities were blocked ([Figures 6c and d](#fig6){ref-type="fig"}).

Discussion
==========

The results demonstrated BPA-induced meiotic abnormalities in the male reproductive system in adult rats. *In vivo*, BPA administration at 200 *μ*g/kg bw/d significantly decreased sperm counts in adult male rats as a result of spermiation inhibition, with no changes in relative body or reproductive organ weight, no alterations in sperm parameters and sperm apoptosis, and no impacts on sex hormone levels. The sperm count reduction was associated with a disruption in meiotic progression and apoptosis in testicular cells, which may have been caused by the persistence of mDSBs in the pachytene stage in male BPA-exposed rats and the ATM/Chk2 signals activation. Using E~2~ and the ER antagonist ICI 182780, we determined that ER signaling mediated BPA-induced reproductive impairments.

The doses of BPA administered in this study are selected with human applicability in mind. Recent studies suggest that an adult is exposed to low concentrations of BPA, no more than 0.4--1.5 *μ*g BPA/kg bw/day.^[@bib23]^ The environmentally human-relevant dose of BPA in rodent experiments is considered as 20 *μ*g/kg bw/day.^[@bib9]^ Although the dose of BPA (200 *μ*g/kg bw/day) that induced significant reproductive impairment in our study cannot be considered truly environmentally relevant, it can be considered low. Based on the available data, a conference sponsored by the National Institute of Environmental Health Sciences in 2007 predicted that internal BPA exposure (plasma or serum concentrations) in humans is \>35 mg/day (∼500 *μ*g/kg/day).^[@bib24]^ Moreover, the actual exposure level may be much higher than the current accepted level in some countries or areas.^[@bib25]^

Epidemiological evidence suggests that increased urine BPA levels are highly associated with decreased sperm concentrations,^[@bib6]^ indicating an underlying link between BPA exposure and sperm production. In the present study, following a 60-day exposure of adult rats to BPA and E~2~, a significant reduction of sperm counts was observed at dosages up to 200 *μ*g/kg/d, which is consistent with previous studies showing that adult BPA exposure adversely affects epididymal sperm counts.^[@bib26],\ [@bib27],\ [@bib28]^ However, some studies that conducted perinatal, neonatal, gestational, or even adult BPA exposure failed to observe any changes in sperm counts,^[@bib29]^ which may be attributed to their different exposure protocols and shorter duration compared with our study.

In rodent testes, the multiple types of germ cells are arranged in characteristic cellular associations that succeed each other in a given area of the seminiferous tubule, which are known as the stages of spermatogenesis. Their succession in time has been defined as the cycle of the seminiferous epithelium. Interestingly, in our study, the BPA- and E~2~-treated groups showed a higher frequency of stage VII and a lower frequency of stage VIII compared with control animals, suggesting a possible delay in the progression of spermiation, which takes place at stage VIII. These results are consistent with previous studies showing that environmental toxin-induced low daily sperm production and low epididymal sperm counts are concomitant with an increased frequency of stage VII^[@bib30]^ and a reduction in the length of stage VIII.^[@bib31]^ Furthermore, BPA and estrogen have also been shown to induce blood--testis barrier restructuring,^[@bib32]^ Sertoli cell junctional protein expression,^[@bib10]^ and germ cell apoptosis, specifically at stages VII and VIII.^[@bib33]^ Although we did not evaluate these changes, our data indicate that the BPA-induced sperm count reduction is highly associated with the disruption of spermatogenesis. However, because the sex hormones important for controlling the process of spermatogenesis were not altered after BPA treatment, we attempted to unequivocally demonstrate how spermatogenesis is disturbed by BPA exposure.

Results from flow cytometric and immunofluorescent analysis of meiotic cells reflected the retention of primary spermatocyes at post-meiotic stage that failed to be differentiated into spermatids following BPA exposure and E~2~ treatment. Meiotic progression is regulated by many factors, including those involved in mDSB repair and homologous recombination, and structural proteins. Mutation of some of the genes involved in mDSB repair results in the arrest of spermatocytes at the pachytene stage,^[@bib34],\ [@bib35]^ suggesting that the pachytene stage may act as a checkpoint to monitor mDSB repair and meiotic events during germ cell development. In the present study, coupled with the retention of pachytene spermatocytes, a marked increase of *γ*H2AX foci formation on the autosomes of pachytene spermatocytes is observed following BPA and E~2~ treatments, indicating that BPA and E~2~ induced the accumulation of mDSBs in pachytene spermatocytes. Additionally, previous studies have also demonstrated that BPA exposure impairs the double-strand break repair machinery, increases the number of homologous recombination protein RAD-51 foci in late pachytene,^[@bib14]^ elevates mismatch repair-related MLH1 foci,^[@bib9],\ [@bib15]^ and upregulates the expression of genes involved in DSB generation (Spo11), signaling (H2AX), and repair (RPA, BML).^[@bib36]^ These results suggest that exposure to a low dose of BPA may lead to the persistence of mDSBs by inhibiting their repair, although high doses of BPA have been reported to be genotoxic.^[@bib37]^ Subsequently, these unresolved mDSBs in pachytene spermatocytes result in the disruption of meiotic progression and chromosome abnormalities, such as asynapsis, chromosomal aberrations, and interrupted regions of SYCP3 staining, as also demonstrated by previous studies.^[@bib9],\ [@bib14]^

In response to DSBs, mammalian cells activate checkpoint kinases and a complex response network, including DNA damage sensors, signal transducers, and effectors which is named as DNA damage response (DDR).^[@bib38],\ [@bib39]^ Two of the major regulators of the DDR are ATM and ataxia--telangiectasia and Rad3-related (ATR).^[@bib40]^ ATM and ATR signals control cell-cycle transitions, DNA replication, DNA repair, and apoptosis. ATM mainly responds to DSBs, whereas ATR reacts to the structures that contain single-stranded DNA.^[@bib41]^ In the present study, concomitant with the persistence of *γ*H2AX, the p-ATM and p-Chk2 are greatly upregulated following BPA 200 and E~2~ treatments, which indicate that the ATM/Chk2 signals are involved in BPA- and E~2~-induced meiotic cycle delay and germ cell apoptosis. In meiosis, the ATM/Chk2 signals regulate meiotic entry and meiotic G(2)/M transition in germ cells.^[@bib42]^ Our results suggest that ATM/Chk2-dependent meiotic cycle delay and germ cell apoptosis may contribute to the BPA- and E~2~-induced sperm count reduction.

BPA is considered a weak estrogen because its binding affinity to ER*α* and ER*β* was estimated to be \>1000--10 000-fold lower than the natural hormone E~2~.^[@bib43]^ However, previous studies have revealed that BPA can promote estrogen-like activities that are similar or stronger than E~2~.^[@bib44]^ We find that BPA acts as an ER agonist to induce persistent mDSBs in pachytene spermatocytes, triggering subsequent meiotic disruption. However, our results are inconsistent with previous studies showing that BPA acts as an ER antagonist to induce meiotic abnormalities.^[@bib9]^ These conflicting outcomes indicate that BPA activity is effect and sex dependent and may be attributed to the differential expression and balance of ERs. In the adult testes and in stages VII--XIV, ER*α* is expressed at higher levels. Its transcripts have been shown to vary according to age, germ cell type, and the stage of the seminiferous epithelium, whereas ER*β* expression is less affected by these.^[@bib45]^ Therefore, our data suggest that the BPA-induced persistence of mDSBs and the subsequent disruption of meiotic disruption are ER dependent. However, it is unclear how ER signaling induces mDSB persistence. It has been demonstrated that estrogen may block ATR activity via plasma membrane-localized ER*α* to inhibit cell-cycle checkpoints and DNA repair.^[@bib46]^ As a result of the persistence of mDSBs and disrupted meiotic progression, the BPA-induced sperm count reduction is also ER dependent, as indicated by a previous study demonstrating that ICI treatment partially reverses the diethylstilbestrol-induced decline in sperm concentration. Nevertheless, ICI treatment has previously been described to have deleterious effects on male reproductive outcomes.^[@bib47]^ In our study, due perhaps to the lower dose or shorter duration of ICI, we failed to observe any alterations following ICI treatment alone.

In summary, our present results suggest that ER-mediated and ATM/Chk2-dependent meiotic disruption may be a major contributor to the molecular events leading to BPA-related male reproductive disorders.

Materials and Methods
=====================

Animal care and diets
---------------------

Male Wistar rats (8 weeks of age) were purchased from the Animal Center of the Third Military Medical University, Chongqing, China. Animal care and use were conducted according to our national and institutional guidelines. All animals were housed under standard conditions (23±1 °C, 55±5% humidity, 12-h light/dark cycle). Animals were provided with a rodent experimental diet from Research Diets (Harlan Teklad, Madison, WI, USA) in which no phytoestrogens could be detected, as introduced by the manufacturer. Water was given from glass bottles *ad libitum*. All animals in this study were treated humanely and with regard for the alleviation of suffering.

Experimental design
-------------------

Rats acclimatized for 1 week were administered BPA (Sigma-Aldrich, St. Louis, MO, USA) by gavage at 0 (ethanol only), 2, 20, and 200 *μ*g/kg bw/day, according to previous studies.^[@bib5],\ [@bib9]^ E~2~ (Sigma-Aldrich) was administered by subcutaneous injection at 10 *μ*g/kg bw/day as an estrogenic-positive control.^[@bib48]^ BPA and E~2~ were dissolved in absolute ethanol and then mixed with corn oil (Sigma-Aldrich) to final absolute ethanol concentration of 0.5%. After treatment, changes in body weight, testis weight, epididymal weight, and epididymal sperm counts were evaluated. For the following experiment, fulvestrant (ICI 182780; Sigma-Aldrich) was used to antagonize ER signaling and was dissolved in absolute ethanol with a final dose of 500 *μ*g/kg bw/day.^[@bib49]^ Acclimatized rats were randomly divided into five groups: control, BPA 200, E~2~, ICI, and ICI+BPA 200. Rats in the ICI and ICI+BPA 200 groups were subcutaneously injected with ICI 30 min before BPA administration. At the same time, rats from the solvent-control-, BPA- and E~2~-treated groups were injected with 0.5% ethanol in corn oil. After 30 min, rats in the BPA and ICI+BPA 200 groups were treated with corn oil-diluted BPA by gavage; rats in the E~2~ group were injected with E~2~ subcutaneously. Meanwhile, rats from the solvent-control-, ICI- and E~2~-treated groups were administered an equivalent volume of corn oil without BPA or E~2~. All treatments were performed for 60 consecutive days to cross one cycle of spermatogenesis (12.9 days/cycle × 4.5 cycles).^[@bib27]^

Collection of biological samples and heart perfusion
----------------------------------------------------

After treatment, rats were anesthetized with 20% urethane. Blood samples were collected from the right ventricle to measure hormone levels. The left epididymis and testicle were removed and weighed, and the cauda epididymis was used for sperm analysis; the left testicle was used for a meiotic chromosomal spread analysis and alkaline comet assay. Then, perfusion-fixation was performed with saline perfusion through the left cardiac ventricle and followed with 4% paraformaldehyde (Sigma-Aldrich). The fixed right epididymis and testicle were used for paraffin sections for hematoxylin and eosin (H&E) or periodic acid schiff-hematoxylin (PAS-H) staining.

Epididymal sperm count, motility, and morphology
------------------------------------------------

As previously described,^[@bib50]^ cauda epididymides were chopped into 2 ml of Ham\'s F-12 (GIBCO, Grand Island, NY, USA) and incubated for 5 min at 37 °C to allow their contents to spread into the medium. Then, 5 *μ*l of epididymal sperm suspension was diluted with 195 *μ*l of Ham\'s F-12 medium. The number of epididymal sperm was determined using a hemocytometer under a light microscope (Leica DM6000 B, Wetzlar, Germany) at 200 × magnification. The final sperm concentration was calculated, and the results were expressed as 10^8^/g epididymal weight. Sperm motility and morphology were examined according to the WHO guidelines. The results were expressed as motile sperm (A+B) (%) and normal sperm morphology (%). For each individual, a total of 300 sperm were examined at × 400 magnification.

Assessment of sperm apoptosis (Annexin V/PI assay)
--------------------------------------------------

Apoptotic sperm was detected using the Annexin V-FITC Apoptosis Detection Kit according to the manufacturer\'s instructions (Roche Diagnostics Corp., Basel, Switzerland). After washing, the sperm pellet was resuspended in Annexin V Binding Buffer (0.01 M HEPES/NaOH, pH 7.2, 0.15 M NaCl, and 2.5 mM CaCl~2~) at room temperature to a concentration of 1 × 10^6^ sperm/ml. Aliquots (100 *μ*l each, 1 × 10^5^ cells) were transferred into 5-ml culture tubes, and 5 *μ*l of Annexin V-FITC+1 *μ*l of PI (50 *μ*g/ml) or nothing was added to each sample. The tubes were slightly mixed and incubated at room temperature for 15 min in the dark. Additional Binding Buffer (400 *μ*l) was added to each tube, and the flow cytometric analysis was performed within 5 min.

Hormone assays
--------------

Because the FSH and LH levels in some rats were below the detection limit of the chemiluminescence immunoassay (CIA) kits, they were measured using radioimmunoassay kits with a detection limit of 1.0 mIU/ml (Beijing North Institute of Biological Technology, Beijing, China). Serum testosterone concentrations were measured by CIA kits with a detection limit of 0.02 ng/ml (Beckman Coulter, Fullerton, CA, USA).

Histological analysis and staging of seminiferous epithelium
------------------------------------------------------------

Fixed epididymides and testes were embedded in paraffin and serially sectioned (5 *μ*m). Epididymides were stained with H&E for histological analysis. Testes were stained with PAS-H to stage the seminiferous epithelium. The sections were analyzed using a Leica light microscope. PAS-H staining and the staging of the rat seminiferous tubules were performed as previously described.^[@bib51]^

Meiocyte spreading and immunofluorescence
-----------------------------------------

Meiocyte spreading was conducted by a drying-down technique.^[@bib20]^ Briefly, decapsulated testes were placed in hypotonic extraction buffer (30 mM Tris, 50 mM sucrose, 17 mM trisodium citrate dehydrate, 5 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, pH 8.2) and incubated on ice for 60 min. One-inch tubules were then placed in 20 *μ*l of sucrose solution (100 mM sucrose, adjusted with NaOH to pH 8.2) and mixed to a cloudy suspension, which was then spread onto two slides dipped in a freshly prepared formaldehyde solution (1% formaldehyde, 0.15% Triton X-100 in water adjusted with sodium borate to pH 9.2). Slides were then dried slowly in humidified chambers for 2--3 h. The immunostaining protocol was adapted from Brower *et al.*^[@bib52]^ Slides were incubated for 15 min in dilution buffer (3% BSA, 0.5% Triton X-100 in PBS). After washing, slides were incubated with mouse monoclonal anti-*γ*H2AX antibodies (1 : 500; phosphor S139, ab18311, Abcam, Cambridge, MA, USA) at 4 °C overnight. The next day, slides were incubated with Alexa Fluor 488-conjugated anti-mouse immunoglobulin G (IgG) (H+L) antibody (1 : 100; Invitrogen Corp., Carlsbad, CA, USA) for 1 h at room temperature. Alternatively, slides were incubated with the primary antibody rabbit polyclonal anti-SYCP3 (1 : 500; ab15093, Abcam) for 1 h at room temperature. Following three 3-min washes in PBS, the slides were incubated with an Alexa Fluor 647-conjugated anti-rabbit IgG (H+L) antibody (1 : 100; Invitrogen). The slides were then washed in PBS, stained with DAPI (Sigma-Aldrich), and analyzed with a Leica confocal laser scanning microscope (TCS SP2, Wetzlar, Germany).

Flow cytometric analysis
------------------------

Part of the testis was used for the preparation of single cells as described by Bastos *et al.*^[@bib53]^ Decapsulated testes were subjected to serial mechanical dissociation and two-step collagenase (GIBCO) enzymatic digestion to obtain a whole-cell suspension that was filtered using 40-*μ*m nylon mesh. The filtered cells were fixed in 75% chilled ethanol and stored at 4 °C for at least 24 h. Fixed testicular cells were washed twice with PBS and treated with 1 ml of staining solution containing 50 *μ*g/ml PI (Sigma-Aldrich), 500 *μ*g/ml RNase (Sigma-Aldrich), and 0.1% Triton X-100 in PBS for 20 min at 37 °C in the dark. The cells were analyzed using a FACSCalibur system (FACSAria, BD Biosciences, CA, USA), counting 30 000 cells in each sample. The testicular cell populations were classified as 1C-, 2C- ,and 4C-DNA content subpopulations according to their DNA content. The percentages of cells in each phase were calculated using the Cell ModFit software program (Becton-Dickinson, Franklin, NJ, USA).

Germ cell purification and alkaline comet assay
-----------------------------------------------

Testicular germ cells were purified as described by Meistrich *et al.*^[@bib54]^ Briefly, filtered testicular cells were subjected to a germ cell isolation procedure using elutriation centrifugation. Further purification was conducted by centrifugation through a linear Percoll density gradient (Pharmacia, Uppsala, Sweden) to discriminate round spermatids, pachytene spermatocytes, and cytoplasts of elongated spermatids. A purity of approximately 69% can be obtained for pachytene spermatocyte isolations, with the contaminating cells consisting of other types of germ cells. Purified germ cells were then subjected to an alkaline comet assay according to the manufacturer\'s instructions (Trevigen, Gaithersburg, MD, USA). Briefly, cells were combined with low melting agarose onto comet slides (Trevigen). After lysis and alkaline unwinding (pH \>13), cells were subjected to electrophoresis for 40 min at an average of 1 V/cm. The resulting comets were visualized with diluted SYBR Green I (Invitrogen) and examined at × 200 magnification with a Leica fluorescence microscope (Germany). At least 50 comet images were obtained for each sample and analyzed with a computer-based image analysis system (Comet Assay Software Project; CASPLab, Wroclaw, Poland). Data indicate the mean tail moment.

Western blotting
----------------

For western blotting, testicular tissues were homogenized in lysis buffer (Beyotime Company, Jiangsu, China) containing a cocktail of protease inhibitors and phosphatase inhibitors (Roche Diagnostics Corp.). After incubation for 30 min at 4 °C, samples were then centrifuged at 15 000 × *g* for 30 min. Supernatants were collected, and the concentration was measured by BCA protein assay kit (Beyotime). Protein extracts from each sample were added to a gel loading buffer (100 mM Tris, pH 6.8, 20% glycerol, 200 mM DTT, 4% SDS, 0.03% bromophenol blue) and boiled for 10 min at 97 °C. Proteins (100 *μ*g/sample) in loading buffer were subjected to electrophoresis in 10% SDS-polyacrylamide gel for 1.5 h. The gel was transferred electrophoretically onto a polyvinylidene fluoridemembrane (Immobilon-P; Millipore Corp., Bedford, MA, USA) and blocked in 5% nonfat powdered milk in PBS for 1 h. The membranes were then incubated with mouse monoclonal antibody against *γ*H2AX or rabbit polyclonal antibody against p-Chk2 (ab59408, Abcam) or Caspase 3 (9662S, Cell Signaling Technology, Beverly, MA, USA) or *β*-actin (Sigma-Aldrich, 1 : 1000) overnight at 4 °C. After washes in PBS containing 0.1% Tween-20 for three times for 5 min each, the membranes were incubated with horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG (Abcam, 1 : 2000). After washes, the blots were developed using an enhanced chemiluminescence (ECL) system (Amersham Corp., CardiV, UK).

TUNEL staining
--------------

For the detection of apoptosis, paraffin-embedded sections were stained with the TUNEL technique using an *in situ* apoptosis detection kit (Roche Diagnostics Corp.) according to the manufacturer\'s introductions. To assess apoptosis in testicular cells, 100 seminiferous tubules were observed in each section at a magnification of × 200. Seminiferous tubules were chosen according to the same criterion. A histogram of the number of TUNEL-positive germ cells in 100 seminiferous tubules was analyzed.

Statistical analysis
--------------------

All data were expressed as means and S.E.M. SPSS 13.0 (SPSS Inc., Chicago, IL, USA) was used to perform the unpaired Student\'s *t*-test for comparisons between the two groups. A *P*-value of \<0.05 was considered statistically significant.
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![Effects of BPA and E~2~ on (**a**) cauda epididymal sperm counts, (**b**) relative body weight, (**c**) testis weight, (**d**) epididymis weight, and (**e**--**l**) the cauda epididymis histology with or without ICI 182780 pretreatment. Rats were treated with BPA (0, 2, 20, 200 *μ*g/kg/d), E~2~ (10 *μ*g/kg/d), or BPA 200 and ICI (500 *μ*g/kg/d) for 60 days. Bars represent the mean±S.E.M. (*n*=eight rats per group), \**P*\<0.05 *versus* control, ^\#^*P*\<0.05 *versus* BPA 200](cddis2013203f1){#fig1}

![Effect of BPA or E~2~ administration on sperm parameters and serum sex hormone levels with or without ICI 182780 pretreatment. No alterations were observed in (**a**) sperm motility, (**b**) percentage of normal sperm morphology, (**c**) apoptotic sperm, (**d**) serum FSH levels, or (**e**) serum LH levels. (**f**) Serum testosterone levels were significantly reduced following E~2~ but not BPA and ICI treatment. Each bar represents the mean±S.E.M. (*n*=eight rats per group). \**P*\<0.05 *versus* control](cddis2013203f2){#fig2}

![Effects of BPA and E~2~ on the seminiferous epithelium stages with or without ICI 182780 pretreatment. (**a**) The percentages of the 14 stages are presented. (**b**) The percentage of stage VII. (**c**) The percentage of stage VIII. Each bar represents the mean±S.E.M. (*n*=eight rats per group), \**P*\<0.05 *versus* control, ^\#^*P*\<0.05 *versus* BPA 200](cddis2013203f3){#fig3}

![Changes in the proportions of testicular cell populations and stages of spermatocytes in meiosis I following BPA and E~2~ treatment with or without ICI 182780 pretreatment. (**A**a--**A**c) Representative fluorescence-activated cell sorting images of all testicular cells from control (**A**a), BPA 200- (**A**b) and E~2~- (**A**c) treated rats. (**B**a--**B**d) The proportion of 1C, 2C, and 4C testicular germ cells (*n*=six rats per group). (**C**a--**C**d) Spermatocytes in the meiosis I stages. Meiotic chromosomal spreads were prepared from freshly dissected testes from normal rats; spermatocytic reparations were stained with SYCP3 (red), mouse *γ*H2AX (green), and DAPI (4,6-diamidino-2-phenylindole; blue). Representative images of leptotene (**C**a), zygotene (**C**b), pachytene (**C**c), and diplotene (**C**d) spermatocytes are shown. (**D**a--**D**d) The percentages of spermatocytes in the meiosis I stages, above 100 pachytene spermatocytes of each rat (*n*=six rats per group) were analyzed. \**P*\<0.05 *versus* control, ^\#^*P*\<0.05 *versus* BPA 200](cddis2013203f4){#fig4}

![Persistence of mDSBs and checkpoint activation assessed by chromosomal spread, comet assay and immunoblot after BPA, E~2~, and/or combined ICI treatment. (**a**) Photomicrographs from the control, BPA 200, and E~2~ groups show abnormal *γ*H2AX foci formation (white circle) and chromosome abnormalities (white arrow) on the autosomes of pachytene spermatocytes; (**b**) photomicrographs show ATM activation on both autosome and XY body in pachytene spermatocytes; (**c**) quantification of *γ*H2AX-positive cells in pachytene spermatocytes, above 100 pachytene spermatocytes of each rat (*n*=six rats per group) were analyzed; (**d**) levels of mDSBs determined by alkaline comet assay; (**e**) immunoblotting analysis of whole-testis lysates showing an accumulation of *γ*H2AX in BPA- or E~2~-treated testis, which can be blocked by ICI pretreatment; (**f**) the levels of phosphospecific forms of Chk2 were assessed using western blot analysis, in which actin served as a loading control, vehicle-treated rats were arbitrarily fixed at 100%. Bars represent the mean±S.E.M. (*n*=six rats per group), \**P*\<0.05 *versus* control, ^\#^*P*\<0.05 *versus* BPA 200](cddis2013203f5){#fig5}

![Germ cell apoptosis evaluated by TUNEL assay and caspase-3 immunoblot after BPA and E~2~ treatment with or without ICI pretreatment. (**a**) Representative micrographs show TUNEL-positive cells (green) on testicular section from control, BPA, and/or ICI-treated rats. Nuclei were counterstained with DAPI (4,6-diamidino-2-phenylindole; blue). (**b**) Quantification of TUNEL analyses. Shown is the number of positive cells per 100 seminiferous tubules of each rat (*n*=six rats per group). (**c**) Immunoblot of active caspase-3 performed on testicular protein extracts. Shown is the representative micrographs. (**d**) Quantification of activated caspase-3 protein accumulation relative to total caspase-3 is shown; vehicle-treated rats were arbitrarily fixed at 100% (*n*=six rats per group). \**P*\<0.05 *versus* control, ^\#^*P*\<0.05 *versus* BPA 200](cddis2013203f6){#fig6}
